The Retinal Pigment Epithelium: Something More than a Constituent of the Blood-Retinal Barrier-Implications for the Pathogenesis of Diabetic Retinopathy

被引:339
作者
Simo, Rafael [1 ]
Villarroel, Marta [1 ]
Corraliza, Lidia [1 ]
Hernandez, Cristina [1 ]
Garcia-Ramirez, Marta [1 ]
机构
[1] Hosp Univ Vall dHebron, Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Unitat Diabet & Metab,Inst Recerca, Barcelona 08035, Spain
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2010年
关键词
ENDOTHELIAL GROWTH-FACTOR; APOLIPOPROTEIN-A-I; PHOTORECEPTOR OUTER SEGMENTS; GLYCATION END-PRODUCTS; BINDING PROTEIN IRBP; HUMAN RPE CELLS; VITREOUS FLUID; MACULAR DEGENERATION; ERYTHROPOIETIN PROTECTS; GENE-EXPRESSION;
D O I
10.1155/2010/190724
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The retinal pigment epithelium (RPE) is an specialized epithelium lying in the interface between the neural retina and the choriocapillaris where it forms the outer blood-retinal barrier (BRB). The main functions of the RPE are the following: (1) transport of nutrients, ions, and water, (2) absorption of light and protection against photooxidation, (3) reisomerization of all-trans-retinal into 11-cis-retinal, which is crucial for the visual cycle, (4) phagocytosis of shed photoreceptor membranes, and (5) secretion of essential factors for the structural integrity of the retina. An overview of these functions will be given. Most of the research on the physiopathology of diabetic retinopathy has been focused on the impairment of the neuroretina and the breakdown of the inner BRB. By contrast, the effects of diabetes on the RPE and in particular on its secretory activity have received less attention. In this regard, new therapeutic strategies addressed to modulating RPE impairment are warranted.
引用
收藏
页数:15
相关论文
共 202 条
  • [71] NEUROPROTECTIVE EFFECT OF ERYTHROPOIETIN AND DARBEPOETIN ALFA AFTER EXPERIMENTAL INTRACEREBRAL HEMORRHAGE
    Grasso, Giovanni
    Graziano, Francesca
    Sfacteria, Alessandra
    Carletti, Fabio
    Meli, Francesco
    Maugeri, Rosario
    Passalacqua, Marcello
    Certo, Francesco
    Fazio, Marco
    Buemi, Michele
    Iacopino, Domenico Gerardo
    [J]. NEUROSURGERY, 2009, 65 (04) : 763 - 769
  • [72] HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration
    Grimm, C
    Wenzel, A
    Groszer, M
    Mayser, H
    Seeliger, M
    Samardzija, M
    Bauer, C
    Gassmann, M
    Remé, CE
    [J]. NATURE MEDICINE, 2002, 8 (07) : 718 - 724
  • [73] Hamann S, 2002, INT REV CYTOL, V215, P395
  • [74] Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye
    Hamann, S
    Zeuthen, T
    La Cour, M
    Ottersen, OP
    Agre, P
    Nielsen, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (05): : C1332 - C1345
  • [75] Hargrave PA, 2001, INVEST OPHTH VIS SCI, V42, P3
  • [76] HAYES KC, 1989, INVEST OPHTH VIS SCI, V30, P225
  • [77] Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
    Heeschen, C
    Aicher, A
    Lehmann, R
    Fichtischerer, S
    Vasa, M
    Urbich, C
    Mildner-Rihm, C
    Martin, H
    Zeiher, AM
    Dimmeler, S
    [J]. BLOOD, 2003, 102 (04) : 1340 - 1346
  • [78] Helboe L, 1999, INVEST OPHTH VIS SCI, V40, P2376
  • [79] Somatostatin molecular variants in the vitreous fluid -: A comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects
    Hernández, C
    Carrasco, E
    Casamitjana, R
    Deulofeu, R
    García-Arumì, J
    Simó, R
    [J]. DIABETES CARE, 2005, 28 (08) : 1941 - 1947
  • [80] Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy -: A case-control study
    Hernández, C
    Burgos, R
    Cantón, A
    García-Arumí, J
    Segura, RM
    Simó, R
    [J]. DIABETES CARE, 2001, 24 (03) : 516 - 521